Limited-Time September Offer: Try 7 Days for Free

Esperion Therapeutics (0IIM.L) Stock Price

$2.8 0%

Sign up
to add to portfolio

AI Score

  • Alternative

    7
  • Fundamental

    1
  • Technical

    8

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.

Sign up to get access to more historical data and insights on Esperion Therapeutics, AI stock picks, stock alerts and much more.

Sign up

0IIM.L AI Stock Analysis

AI stock analysis for 0IIM.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Esperion Therapeutics (0IIM.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Esperion Therapeutics (0IIM.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Esperion Therapeutics (0IIM.L), currently trading at $2.8, will... Sign up to access price prediction.

About 0IIM.L

LSE
  • Esperion Therapeutics, Inc.

  • Symbol

    0IIM.L

  • Market

    LSE

  • Industry

    Medical - Pharmaceuticals

  • Market Cap

    549.2M

0IIM.L Alternative Data

Web Traffic

Esperion Therapeutics receives an estimated 17354 monthly visitors to esperion.com, which is up by 90.7% over the last month.

  • Web Traffic

    17354

  • Change from Previous Month

    90.7%

  • 3 Month Change

    113.5%

  • YoY Change

    113.5%

Twitter Followers

Esperion Therapeutics has 2,128 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.7% over the last month.

  • Twitter Followers

    2128

  • Daily Change

    0%

  • 1 Month Change

    0.7%

  • 3 Month Change

    1.3%

  • YoY Change

    1.3%

LinkedIn Followers

21,584 are following Esperion Therapeutics on LinkedIn, up by 2.4% over the last month.

  • LinkedIn Followers

    21584

  • Daily Change

    1.3%

  • 1 Month Change

    2.4%

  • 3 Month Change

    4.3%

  • YoY Change

    4.3%

Job Postings

Esperion Therapeutics currenly has an estimated 19 open job postings, up by 35.7% over the last month.

  • Job Postings

    19

  • Daily Change

    0%

  • 1 Month Change

    35.7%

  • 3 Month Change

    26.7%

  • YoY Change

    26.7%

LinkedIn Employees

According to LinkedIn, Esperion Therapeutics has 347 employees, up by 0.6% over the last month.

  • LinkedIn Employees

    347

  • Daily Change

    0.9%

  • 1 Month Change

    0.6%

  • 3 Month Change

    2.1%

  • YoY Change

    2.1%

Reddit Mentions

Esperion Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at Esperion Therapeutics is 57 out of 100 (neutral).

  • Business Outlook

    57

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

News Mentions

Esperion Therapeutics was mentioned 2 times in the news yesterday.

  • News Mentions

    2

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

0IIM.L Financials

0IIM.L Key Metrics
  • Total Revenue

    $65M

  • Net Income

    -$40.5M

  • Earnings per Share

    -$0.21

  • Free cash flow

    -$22.6M

  • EBITDA

    -$21M

  • EBITDA Ratio

    -0.323071

  • Total Assets

    $324M

0IIM.L 2-year Revenue & Income
0IIM.L 2-year Free Cash Flow

0IIM.L Technicals

0IIM.L SMA
0IIM.L RSI

FAQ

What's the current price of Esperion Therapeutics (0IIM.L) Stock?
The price of an Esperion Therapeutics (0IIM.L) share is $2.8.

What's the market cap of Esperion Therapeutics?
The current market cap of Esperion Therapeutics is 549.2M.

What are some stocks similar to Esperion Therapeutics (0IIM.L) that investors often compare it to?
Esperion Therapeutics (0IIM.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Thermo Fisher Scientific Inc..

What is the forecast for Esperion Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Esperion Therapeutics' stock price to be around $2.87 in 2026. Starting from the current price of $2.8, this represents a 2.4% change in price, indicating a neutral outlook for the stock.

How to buy Esperion Therapeutics (0IIM.L) Stock?
Esperion Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Esperion Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.